Ondine Biomedical Inc. (LON:OBI - Get Free Report)'s stock price was up 10% during trading on Monday . The company traded as high as C$11.50 and last traded at C$11.00. Approximately 330,109 shares traded hands during trading, an increase of 40% from the average daily volume of 236,293 shares. The stock had previously closed at C$10.00.
Ondine Biomedical Trading Up 5.9%
The firm has a market capitalization of C$103.54 million, a price-to-earnings ratio of -4.34 and a beta of 0.10. The company has a quick ratio of 8.26, a current ratio of 1.36 and a debt-to-equity ratio of 25.95. The business's fifty day moving average is C$9.30 and its 200 day moving average is C$9.81.
About Ondine Biomedical
(
Get Free Report)
Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens.
Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings.
Featured Stories
Before you consider Ondine Biomedical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ondine Biomedical wasn't on the list.
While Ondine Biomedical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
